search
Back to results

Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions (TELEMARC2)

Primary Purpose

Arrhythmia, Children

Status
Unknown status
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Prolonged telemetric Full Disclosure ECG recording.
Repeated 24 hours ECG Holter monitoring
Sponsored by
National Institute of Cardiology, Warsaw, Poland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Arrhythmia focused on measuring Arrhythmia, Children

Eligibility Criteria

undefined - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • History of symptoms that can be potentially caused by cardiac arrhythmia occuring at least 4 times a year
  • Ability to operate the telemetric device at home
  • Informed consent undersigned by the parents
  • Informed consent undersigned by the child if over 16 years of age

Exclusion Criteria:

  • Previously recorded tachycardia evidence
  • Wolff Parkinson White syndrome
  • Inability to operate the telemetric device at home
  • Inability to comply with the study protocol

Sites / Locations

  • Medical University of Warsaw Department of Pediatric Cardiology and General PediatricsRecruiting
  • Institute of CardiologyRecruiting
  • The Children's Memmorial Health InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Telemetry ordered by a Cardiologist

24 hours standard Holter monitoring

Telemetry ordered by a Pediatrician

Arm Description

Outcomes

Primary Outcome Measures

Recording of symptomatic or life threatening arrhythmia event
ECG monitoring is conducted until occurrence of symptomatic arrhythmia or life threatening arrhythmia but not longer than 30 days. Patients in the control group will have standard ECG Holter monitoring repeated twice

Secondary Outcome Measures

Occurrence of silent (asymptomatic) arrhythmia event
Verification of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale against evidence of cardiac arrhythmia occurrence

Full Information

First Posted
December 22, 2010
Last Updated
December 2, 2011
Sponsor
National Institute of Cardiology, Warsaw, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT01265771
Brief Title
Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions
Acronym
TELEMARC2
Official Title
Optimizing Diagnostics And Therapy Of Arrhythmia And Syncope Events Using Intelligent Telemetric Solutions. Diagnostics Of Arrhythmia In Children
Study Type
Interventional

2. Study Status

Record Verification Date
December 2011
Overall Recruitment Status
Unknown status
Study Start Date
February 2011 (undefined)
Primary Completion Date
December 2012 (Anticipated)
Study Completion Date
January 2013 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute of Cardiology, Warsaw, Poland

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to assess efficacy of prolonged Full Disclosure electrocardiogram (ECG) monitoring and signal analysis using advanced telemetric technology to diagnose arrhythmia in comparison with standard diagnostic procedure.
Detailed Description
Irregular and/or rapid beating of the heart called heart palpitations can occur in individuals without heart disease and the reasons for their palpitations are unknown. Together with heart palpitations silent arrhythmia may be present that could lead to serious complications (eg. stroke). In others, palpitations result from heart rhythm disturbances, sometimes life threatening. Standard diagnostic methods such as 24 hours Holter electrocardiogram (ECG) monitoring or Event Holter do not guarantee early diagnosis of the arrhythmia. Prolonged heart rhythm recording and analysis using an automatic full disclosure telemetric device can increase probability of arrhythmia diagnosis and early administration of applicable treatment. Study patients will be diagnosed using standard Holter ECG monitoring, Event Holter or 30 days telemetric ECG monitoring. Efficacy of telemetric monitoring in diagnosis of cardiac arrhythmia will be assessed in comparison with the standard Holter monitoring and Event Holter

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arrhythmia, Children
Keywords
Arrhythmia, Children

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Telemetry ordered by a Cardiologist
Arm Type
Experimental
Arm Title
24 hours standard Holter monitoring
Arm Type
Experimental
Arm Title
Telemetry ordered by a Pediatrician
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Prolonged telemetric Full Disclosure ECG recording.
Other Intervention Name(s)
Pocket ECG, Medicalgorithmics
Intervention Description
Thirty days Telemetric Full Disclosure ECG monitoring; subsequently analyzed in the Event Holter monitoring mode
Intervention Type
Device
Intervention Name(s)
Repeated 24 hours ECG Holter monitoring
Intervention Description
Repeated 24 hours ECG Holter monitoring
Primary Outcome Measure Information:
Title
Recording of symptomatic or life threatening arrhythmia event
Description
ECG monitoring is conducted until occurrence of symptomatic arrhythmia or life threatening arrhythmia but not longer than 30 days. Patients in the control group will have standard ECG Holter monitoring repeated twice
Time Frame
within 30 days since the start of monitoring
Secondary Outcome Measure Information:
Title
Occurrence of silent (asymptomatic) arrhythmia event
Time Frame
within 30 days since the start of monitoring
Title
Verification of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale against evidence of cardiac arrhythmia occurrence
Time Frame
within 30 days since the start of monitoring

10. Eligibility

Sex
All
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: History of symptoms that can be potentially caused by cardiac arrhythmia occuring at least 4 times a year Ability to operate the telemetric device at home Informed consent undersigned by the parents Informed consent undersigned by the child if over 16 years of age Exclusion Criteria: Previously recorded tachycardia evidence Wolff Parkinson White syndrome Inability to operate the telemetric device at home Inability to comply with the study protocol
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Katarzyna Bieganowska, Prof. MD PhD
Email
kbieganowska@wp.pl
First Name & Middle Initial & Last Name or Official Title & Degree
Maria Miszczak-Knecht, MD PhD
Email
mmknecht@neostrada.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lukasz Szumowski, Prof. MD PhD
Organizational Affiliation
National Institute of Cardiology, Warsaw, Poland
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Katarzyna Bieganowska, Prof. MD PhD
Organizational Affiliation
Children's Memorial Health Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of Warsaw Department of Pediatric Cardiology and General Pediatrics
City
Warsaw
ZIP/Postal Code
00-576
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bożena Werner, MD PhD
Phone
(+48 22) 629 83 17
Email
kardiologia@litewska.edu.pl
First Name & Middle Initial & Last Name & Degree
Bożena Werner, MD PhD
First Name & Middle Initial & Last Name & Degree
Tomasz Florianczyk, MD
Facility Name
Institute of Cardiology
City
Warsaw
ZIP/Postal Code
04-620
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lukasz Szumowski, Prof
Email
lszumowski@ikard.pl
First Name & Middle Initial & Last Name & Degree
Lukasz Szumowski, Prof
First Name & Middle Initial & Last Name & Degree
Zbigniew Jedynak, dr
Facility Name
The Children's Memmorial Health Institute
City
Warsaw
ZIP/Postal Code
04-730
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katarzyna Bieganowska, Prof. MD PhD
Email
kbieganowska@wp.pl
First Name & Middle Initial & Last Name & Degree
Maria Miszczak-Knecht, MD PhD
Email
mmknecht@neostrada.pl
First Name & Middle Initial & Last Name & Degree
Katarzyna Bieganowska, Prof
First Name & Middle Initial & Last Name & Degree
Maria Miszczak-Knecht, MD, PhD

12. IPD Sharing Statement

Learn more about this trial

Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions

We'll reach out to this number within 24 hrs